Source: Eur Respir Monogr 2021; 94: 69-85



Rating:

Share or cite this content

Citations should be made in the following way:
Sarah Abdelhafeez, Derek Doherty. Can the immune system be targeted to treat COVID-19?. Eur Respir Monogr 2021; 94: 69-85

Member's Comments

No comment yet.

Related content which might interest you: How to evaluate the immune response in the tissue? Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 Improving the innate immune response in respiratory infections: the use of repurposed drugs Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Adaptive immune system in COPD: auto-immunity or bystander? Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD" Year: 2012 Do antimicrobial peptides shape the adaptive immune response? Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease Year: 2005 The adaptive immune system, autoimmunity and COPD: lessons from animal models Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 How to use new immunosuppressive drugs in lung transplantation Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation Year: 2006 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 Dysregulation of host defence peptides by environmental challenge: Can we mitigate the pathophysiology? Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Surgery in the era of immune and targeted therapy Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care Year: 2021 Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk? Source: Eur Respir J, 58 (1) 2100342; 10.1183/13993003.00342-2021 Year: 2021 Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Ageing of the immune system: a contribution to lung disease? Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung Year: 2012 The future of targeted therapies for sarcoidosis Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis Year: 2005 Differentiating between virus-driven host immune responses and host defence immune responses Source: International Congress 2015 – Mechanisms of virus-driven and host-defence immune responses in acute virus-induced asthma Year: 2015 How do antigen presenting cells see pathogens and cells? Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases Year: 2006 Trained immunity: a way of improving respiratory health through innate immune memory Source: International Congress 2019 – Scientific Year in review Year: 2019